In compliance to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018; Fredun Pharmaceuticals has informed that it enclosed Certificate dated January 02, 2023 received from the SEBI Registered Registrar and Share Transfer Agent (RTA) - Purva Sharegistry (India) for the quarter ended December 31, 2022.
The above information is a part of company’s filings submitted to BSE.